Seventh Annual Society of Thoracic Surgeons Pedimacs Report.
Cardiomyopathy
Congenital Heart Disease
Pediatric
Ventricular Assist Device
Journal
The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R
Informations de publication
Date de publication:
18 Dec 2023
18 Dec 2023
Historique:
received:
06
09
2023
revised:
01
11
2023
accepted:
20
11
2023
medline:
21
12
2023
pubmed:
21
12
2023
entrez:
20
12
2023
Statut:
aheadofprint
Résumé
The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs), supported by The Society of Thoracic Surgeons, provides detailed information on pediatric patients supported with ventricular assist devices (VADs). From September 19, 2012 to December 31, 2022 there were 1463 devices in 1219 patients under 19 years of age reported to the registry from 40 North American Hospitals. Cardiomyopathy remains the most common underlying etiology (59%), followed by congenital heart disease (CHD) (26%) and myocarditis (8%). Regarding device type, implantable continuous (IC) were most common (39%), followed by paracorporeal pulsatile (PP) (28%), and paracorporeal continuous (27%). At six months post-VAD implantation, a favorable outcome (transplant, recovery, or alive on device) was achieved in 85% of patients, which was greatest among those on IC VADs (92%) and least for PC VADs (68%), though the patient population supported on these devices are different. This Seventh Pedimacs Report demonstrates the continued importance of VADs in the treatment of children. With the complexity of cardiac physiologies and sizes of patients, there are multiple types of devices utilized including PC, PP, and IC. The preoperative risk factors and differences in patient populations may account for some of the differences in survival observed among these devices. This report along with other collaborative work continues to advance the care of this challenging and vulnerable population.
Sections du résumé
BACKGROUND
BACKGROUND
The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs), supported by The Society of Thoracic Surgeons, provides detailed information on pediatric patients supported with ventricular assist devices (VADs).
METHODS
METHODS
From September 19, 2012 to December 31, 2022 there were 1463 devices in 1219 patients under 19 years of age reported to the registry from 40 North American Hospitals.
RESULTS
RESULTS
Cardiomyopathy remains the most common underlying etiology (59%), followed by congenital heart disease (CHD) (26%) and myocarditis (8%). Regarding device type, implantable continuous (IC) were most common (39%), followed by paracorporeal pulsatile (PP) (28%), and paracorporeal continuous (27%). At six months post-VAD implantation, a favorable outcome (transplant, recovery, or alive on device) was achieved in 85% of patients, which was greatest among those on IC VADs (92%) and least for PC VADs (68%), though the patient population supported on these devices are different.
CONCLUSIONS
CONCLUSIONS
This Seventh Pedimacs Report demonstrates the continued importance of VADs in the treatment of children. With the complexity of cardiac physiologies and sizes of patients, there are multiple types of devices utilized including PC, PP, and IC. The preoperative risk factors and differences in patient populations may account for some of the differences in survival observed among these devices. This report along with other collaborative work continues to advance the care of this challenging and vulnerable population.
Identifiants
pubmed: 38123046
pii: S0003-4975(23)01297-3
doi: 10.1016/j.athoracsur.2023.11.035
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023. Published by Elsevier Inc.